- Home
- ORIC vs PSEC Comparison
ORIC vs PSEC Comparison
Compare ORIC & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | PSEC |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORIC | PSEC |
|---|---|---|
| Price | $10.11 | $3.01 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 13 | 1 |
| Target Price | ★ $19.73 | $2.50 |
| AVG Volume (30 Days) | 1.4M | ★ 4.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.70% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.90 | $2.45 |
| 52 Week High | $14.93 | $4.47 |
Technical Indicators
Market Signals| Indicator | ORIC | PSEC |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 65.01 |
| Support Level | $9.70 | $2.86 |
| Resistance Level | $10.60 | $2.99 |
| Average True Range (ATR) | 0.78 | 0.11 |
| MACD | -0.16 | 0.02 |
| Stochastic Oscillator | 16.94 | 78.64 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.